Tabatha Jeanette Snyder, PHARMD in Larned, KS - Pharmacist

Tabatha Jeanette Snyder, PHARMD is a Pharmacist based in Larned, Kansas. Tabatha Jeanette Snyder is licensed to practice in Kansas (license number 1-15947) and her current practice location is 920 W 2nd St, Larned, Kansas. She can be reached at her office (for appointments etc.) via phone at (620) 804-0101.

NPI number for Tabatha Jeanette Snyder is 1104266055 and her current mailing address is 920 W 2nd St, Larned, Kansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1104266055.

Contact Information

	Tabatha Jeanette Snyder, PHARMD
	920 W 2nd St, Larned, KS 67550-3810
	(620) 804-0101
	Not Available

Healthcare Provider's Profile

Full Name	Tabatha Jeanette Snyder
Gender	Female
Speciality	Pharmacist
Location	920 W 2nd St, Larned, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1104266055
Provider Enumeration Date: 06/25/2013
Last Update Date: 06/25/2013

Medical Identifiers

Medical identifiers for Tabatha Jeanette Snyder such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1104266055	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	1-15947 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tabatha Jeanette Snyder is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Tabatha Jeanette Snyder, PHARMD 920 W 2nd St, Larned, KS 67550-3810 Ph: (620) 804-0101	Tabatha Jeanette Snyder, PHARMD 920 W 2nd St, Larned, KS 67550-3810 Ph: (620) 804-0101

News Archive

3D printing technology to support bone healing acquired by DePuy Synthes

DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.

Blockade Medical's Barricade Coil System receives CE Mark

Blockade Medical announced today that it has received CE Mark (Conformité Européenne) for its Barricade Coil System. The Barricade Coil System is designed to remove or endovascularly occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.

Centric Health enters agreement to acquire majority stake in Performance Medical Group

Centric Health Corporation, Canada's leading diversified healthcare company, today announced that it has entered into an agreement to acquire 75% of the issued and outstanding securities of Performance Orthotics Inc., Footcare Dispensary Inc., and Foot Stress Inc..

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

In what has the potential to significantly change how Corona patients are being treated and the severity of the disease, research spearheaded at Jerusalem's Hebrew University gathered early clinical evidence demonstrating the efficacy of an existing drug in treating COVID-19.

SARS-CoV-2 immune responses in nursing home residents after full vaccination with Pfizer-BioNTech COVID-19 vaccine

A new study assesses antibody and functional T-cell responses at 6 months after complete vaccination with the Pfizer-BioNTech vaccine.

Tabatha Jeanette Snyder, PHARMD - Pharmacist in Larned, KS